Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122613845 | 12261384 | 5 | F | 20160211 | 20160629 | 20160412 | 20160712 | EXP | CA-GILEAD-2016-0199915 | GILEAD | 64.00 | YR | M | Y | 0.00000 | 20160712 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122613845 | 12261384 | 1 | PS | ZYDELIG | IDELALISIB | 1 | Oral | 150 MG, BID | Y | 205858 | 150 | MG | TABLET | BID | |||||
| 122613845 | 12261384 | 2 | SS | ZYDELIG | IDELALISIB | 1 | Unknown | UNK | Y | 205858 | TABLET | ||||||||
| 122613845 | 12261384 | 3 | SS | ZYDELIG | IDELALISIB | 1 | Oral | UNK | Y | 205858 | TABLET | ||||||||
| 122613845 | 12261384 | 4 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | U | 0 | |||||||||
| 122613845 | 12261384 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 122613845 | 12261384 | 6 | C | MULTIVITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 122613845 | 12261384 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122613845 | 12261384 | 1 | Non-Hodgkin's lymphoma unspecified histology indolent |
| 122613845 | 12261384 | 4 | Malaise |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122613845 | 12261384 | OT |
| 122613845 | 12261384 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122613845 | 12261384 | Aspartate aminotransferase increased | |
| 122613845 | 12261384 | Asthenia | |
| 122613845 | 12261384 | Chills | |
| 122613845 | 12261384 | Decreased appetite | |
| 122613845 | 12261384 | Dehydration | |
| 122613845 | 12261384 | Diarrhoea | |
| 122613845 | 12261384 | Dyspnoea | |
| 122613845 | 12261384 | Erythema | |
| 122613845 | 12261384 | Hepatic enzyme abnormal | |
| 122613845 | 12261384 | Infection | |
| 122613845 | 12261384 | Influenza like illness | |
| 122613845 | 12261384 | Malaise | |
| 122613845 | 12261384 | Pyrexia | |
| 122613845 | 12261384 | Rash | |
| 122613845 | 12261384 | Renal failure | |
| 122613845 | 12261384 | Unevaluable event | |
| 122613845 | 12261384 | Visual impairment | |
| 122613845 | 12261384 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122613845 | 12261384 | 1 | 20160210 | 20160322 | 0 | |
| 122613845 | 12261384 | 2 | 20160401 | 20160402 | 0 | |
| 122613845 | 12261384 | 3 | 20160410 | 20160617 | 0 | |
| 122613845 | 12261384 | 4 | 201605 | 0 |